Suresh S. Ramalingam, MD, FASCO (@ramalingammd) 's Twitter Profile
Suresh S. Ramalingam, MD, FASCO

@ramalingammd

Executive Director @WinshipAtEmory | Professor @EmoryUniversity |Associate VP for Cancer, Woodruff Health Sciences Center I Opinions are my own.

ID: 61662547

linkhttps://winshipcancer.emory.edu/suresh-ramalingam calendar_today31-07-2009 02:03:08

1,1K Tweet

5,5K Followers

933 Following

Winship Cancer Institute of Emory University (@winshipatemory) 's Twitter Profile Photo

Join us for the annual Winship Scientific Symposium at the Emory Conference Center Hotel on Monday, Nov. 11, 2024. Registration is complimentary and includes meals and refreshments. ➡️Register today: apps.winshipcancer.emory.edu/admin/Event/63…

Join us for the annual Winship Scientific Symposium at the Emory Conference Center Hotel on Monday, Nov. 11, 2024. Registration is complimentary and includes meals and refreshments. ➡️Register today: apps.winshipcancer.emory.edu/admin/Event/63…
Winship Cancer Institute of Emory University (@winshipatemory) 's Twitter Profile Photo

Ten research teams co-led by investigators from Winship and the American Cancer Society (American Cancer Society) have been awarded a total of $1 million in pilot grant funding to accelerate research in cancer. ➡️Learn more: brnw.ch/21wOy1n

Ten research teams co-led by investigators from Winship and the American Cancer Society (<a href="/AmericanCancer/">American Cancer Society</a>) have been awarded a total of $1 million in pilot grant funding to accelerate research in cancer. ➡️Learn more: brnw.ch/21wOy1n
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

❓ What role does social media play in bridging the gap for those who cannot attend meetings like #ESMO24 in person? Hear from our #SoMe Editor Dr. Gil Morgan (Gil Morgan, MD) on how OncoAlert amplifies impactful findings & fosters rich discussion: cancerspeak.podbean.com/e/key-highligh…

ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

A new commentary published just in time for Day 1 of #SABCS24 covers past-year top advances in early-stage and metastatic #BreastCancer. Hear from author Kevin Kalinsky, MD, MS, FASCO below & access the article: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… OncoAlert Winship Cancer Institute of Emory University Ruth O'Regan Suresh S. Ramalingam, MD, FASCO

Suresh S. Ramalingam, MD, FASCO (@ramalingammd) 's Twitter Profile Photo

A pt of mine on Keytruda for NSCLC had restaging scans last week. Before I had a chance to meet the patient to discuss results, Humana insurance sent a letter to him that he has progressed and will no longer be covered for keytruda. Has any of you encountered this? #LCSM .

Winship Cancer Institute of Emory University (@winshipatemory) 's Twitter Profile Photo

This year, Winship teams led groundbreaking research, advanced patient care and helped Winship achieve significant milestones, demonstrating their extraordinary dedication and impact. Revisit some of the highlights in our Year-in-Review video.

Winship Cancer Institute of Emory University (@winshipatemory) 's Twitter Profile Photo

Winship joins the Emory community and the world in mourning the passing of President Jimmy Carter. It was truly our honor and privilege to provide his cancer care at Winship in 2015. Our deepest condolences to his family for their loss. 💙➡️ brnw.ch/21wPHNF

Winship joins the Emory community and the world in mourning the passing of President Jimmy Carter. It was truly our honor and privilege to provide his cancer care at Winship in 2015. Our deepest condolences to his family for their loss. 💙➡️ brnw.ch/21wPHNF
Winship Cancer Institute of Emory University (@winshipatemory) 's Twitter Profile Photo

Join us on March 13-14, 2025, for postdoctoral recruitment event at Winship! Network with mentors and postdocs, and explore Emory's research and career resources. 📅 Apply by January 31, 2025 🔗 Details & Application: brnw.ch/21wPrWk

Join us on March 13-14, 2025, for postdoctoral recruitment event at Winship! Network with mentors and postdocs, and explore Emory's research and career resources. 📅 Apply by January 31, 2025 🔗 Details &amp; Application: brnw.ch/21wPrWk
Hagop Kantarjian,MD (@drhkantarjian) 's Twitter Profile Photo

Check out our comprehensive review on #AML from an MD Anderson Cancer Center perspective, " Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges" published in ACS Journal Cancer acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #leusm

Check out our comprehensive review on #AML from an <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> perspective, " Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges" published in <a href="/JournalCancer/">ACS Journal Cancer</a> 

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…
#leusm
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

The latest #CancerAnnualReport is here & reveals that cancer deaths in both men & women declined for more than 20 years, even during the first 2 years of the #COVID19 pandemic. Read the key trends: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… OncoAlert Ahmedin Jemal ACSNews National Cancer Institute CDC NAACCR, Inc.

The latest #CancerAnnualReport is here &amp; reveals that cancer deaths in both men &amp; women declined for more than 20 years, even during the first 2 years of the #COVID19 pandemic.

Read the key trends: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… 

<a href="/OncoAlert/">OncoAlert</a> <a href="/AhJemal/">Ahmedin Jemal</a> <a href="/ACSNews/">ACSNews</a> <a href="/theNCI/">National Cancer Institute</a> <a href="/CDCgov/">CDC</a> <a href="/NAACCR/">NAACCR, Inc.</a>
ACS Journal Cancer (@journalcancer) 's Twitter Profile Photo

This new review article led by Hagop Kantarjian,MD & colleagues details the ongoing revolutionary paradigm shift in acute lymphoblastic leukemia (ALL) treatment, focusing on adult ALL and breakthrough targeted treatments: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert #LeuSM

This new review article led by <a href="/DrHKantarjian/">Hagop Kantarjian,MD</a> &amp; colleagues details the ongoing revolutionary paradigm shift in acute lymphoblastic leukemia (ALL) treatment, focusing on adult ALL and breakthrough targeted treatments: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… <a href="/OncoAlert/">OncoAlert</a> #LeuSM